Shanghai Shen Lian Biomedical Corporation (SHA:688098)
China · Delayed Price · Currency is CNY 9.66
+0.06 (0.63%)
Feb 13, 2026, 3:00 PM CST
SHA:688098 Market Cap
SHA:688098 has a market cap or net worth of 3.97 billion as of February 13, 2026. Its market cap has increased by 85.06% in one year.
Market Cap
3.97B
Enterprise Value
3.86B
Revenue
292.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.66
Market Cap Chart
Since October 28, 2019, SHA:688098's market cap has decreased from 15.08B to 3.97B, a decrease of -73.70%. That is a compound annual growth rate of -19.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 3.97B | 8.78% |
| Dec 31, 2025 | 3.65B | 62.34% |
| Dec 31, 2024 | 2.25B | -26.87% |
| Dec 29, 2023 | 3.07B | -5.79% |
| Dec 30, 2022 | 3.26B | -28.08% |
| Dec 31, 2021 | 4.53B | -31.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hinova Pharmaceuticals | 4.50B |
| Guanhao Biotech | 4.15B |
| Zhejiang Shouxiangu Pharmaceutical | 4.11B |
| Boji Medical Technology | 4.07B |
| Zhejiang Wecome Pharmaceutical Company | 4.03B |
| Qingdao Vland Biotech INC. | 4.01B |
| Shenzhen Bioeasy Biotechnology | 4.00B |
| Baolingbao Biology | 3.97B |